ACCD Live signals | Maximize Profits with Getagraph.com

BUY 136366 min ago

@ $13.03

Issued: 14 Feb 2024 @ 15:30

Return: -42.59%

Previous signal: Feb 13 - 15:53

Previous signal: Sell

Return: 2.93 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Stats
Today's Volume	534 344
Average Volume	655 085
Market Cap	586.11M
EPS	$0 ( 2024-04-25 )
Next earnings date	( $-0.0700 ) 2024-06-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.62
ATR14	$0.0100 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-10	Hilton Michael W	Buy	183	Common Stock
2024-05-10	Hilton Michael W	Sell	183	Restricted Stock Units
2024-05-10	Barnes Stephen H.	Buy	770	Common Stock
2024-05-13	Barnes Stephen H.	Sell	214	Common Stock
2024-05-10	Barnes Stephen H.	Sell	770	Restricted Stock Units

INSIDER POWER
12.55
Last 100 transactions
Buy: 47 172 \| Sell: 35 993

Volume Correlation

Long: 0.55 (weak)

Short: 0.85 (strong)

Signal:(84.618) Same movement expected

Accolade, Inc. Correlation

10 Most Positive Correlations
CNTG	0.912
FXNC	0.91
SIRI	0.899
PEV	0.895
AKAN	0.894
FANH	0.889
EEIQ	0.889
LCFY	0.889
IMKTA	0.888
BPTH	0.887

10 Most Negative Correlations
PRIM	-0.917
FRLA	-0.908
WING	-0.908
SFM	-0.901
WFRD	-0.899
FANG	-0.897
PNTG	-0.897
VCTR	-0.897
SHLD	-0.896
PPC	-0.893

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Accolade, Inc. Correlation - Currency/Commodity

-0.27
( neutral )

0.62
( weak )

0.00
( neutral )

0.67
( moderate )

0.08
( neutral )

-0.48
( neutral )

Accolade, Inc. Financials

Annual	2024
Revenue:	$414.29M
Gross Profit:	$143.63M (34.67 %)
EPS:	$-1.330

FY	2024
Revenue:	$414.29M
Gross Profit:	$143.63M (34.67 %)
EPS:	$-1.330

FY	2024
Revenue:	$414.29M
Gross Profit:	$192.06M (46.36 %)
EPS:	$-0.00130

FY	2023
Revenue:	$363.14M
Gross Profit:	$164.24M (45.23 %)
EPS:	$-6.45

Financial Reports:

No articles found.

Accolade, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Accolade, Inc.

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.